Sanofi Sues Apotex Over Cancer Treatment

Law360, New York (August 12, 2008, 12:00 AM EDT) -- Apotex Inc. infringed two patents when it sought regulatory approval to tap into the growing U.S. market for the cancer treatment Taxotere, according to a complaint filed Friday by French drug company Aventis Pharma SA.

Aventis Pharma and Sanofi-Aventis US LLC filed the lawsuit in the U.S. District Court for the District of Delaware.

Friday's complaint says Apotex sought the U.S. Food and Drug Administration's approval to market a generic form of docetaxel injection solution before the expiration of several Sanofi-Aventis patents, two of which are...
To view the full article, register now.